KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Other Working Capital Changes (2016 - 2025)

Jazz Pharmaceuticals has reported Other Working Capital Changes over the past 16 years, most recently at -$27.5 million for Q4 2025.

  • Quarterly results put Other Working Capital Changes at -$27.5 million for Q4 2025, down 220.35% from a year ago — trailing twelve months through Dec 2025 was -$29.0 million (down 231.15% YoY), and the annual figure for FY2025 was -$29.0 million, down 231.15%.
  • Other Working Capital Changes for Q4 2025 was -$27.5 million at Jazz Pharmaceuticals, down from $6.7 million in the prior quarter.
  • Over the last five years, Other Working Capital Changes for JAZZ hit a ceiling of $127.6 million in Q4 2023 and a floor of -$36.3 million in Q1 2025.
  • Median Other Working Capital Changes over the past 5 years was $1.9 million (2023), compared with a mean of $9.6 million.
  • Biggest five-year swings in Other Working Capital Changes: surged 3284.69% in 2023 and later crashed 846.93% in 2025.
  • Jazz Pharmaceuticals' Other Working Capital Changes stood at $84.9 million in 2021, then crashed by 111.57% to -$9.8 million in 2022, then soared by 1398.33% to $127.6 million in 2023, then crashed by 82.09% to $22.8 million in 2024, then tumbled by 220.35% to -$27.5 million in 2025.
  • The last three reported values for Other Working Capital Changes were -$27.5 million (Q4 2025), $6.7 million (Q3 2025), and $28.1 million (Q2 2025) per Business Quant data.